Standardizing Right Hemicolectomy for Colon Cancer

NCT ID: NCT04889456

Last Updated: 2021-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

930 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-01

Study Completion Date

2027-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A surgical intervention might be highly variable amongst surgeons and centers. This variability has a potential relevance concerning clinical outcomes.

For right-sided colon cancer, the laparoscopic right hemicolectomy (LRHC) knows substantial variation. Especially since the surgical technique has been evolving during the latest decade with the introduction of intracorporeal anastomosis, a dissection technique within the correct embryological planes (complete mesocolic excision) and central vascular ligation of the segmental branches at its origin, resulting in an optimal lymph node dissection.

Given the insights from recent studies showing the association between quality of surgery and relevant clinical outcomes, there is a great need for a formative quality assessment of LRHC. Detailed objective assessment of the LRHC is currently not performed in clinical practice nor in surgical training. Quality assessment of LRHC has great potential to improve surgical training and furthermore, implementation of a standardized technique will ultimately lead to better quality of care for patients suffering from right-sided colon cancer.

The main objective of this study is to improve surgical outcomes for patient with right-sided colon cancer by a prospective sequential interventional cohort study that aims to standardize the surgical technique with subsequent controlled implementation after standardized review of the current practice in a nationwide multicenter setting. The primary endpoint is the 30-day morbidity according to the Clavien-Dindo classification system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Prospective mapping of current practice with surgical variations in laparoscopic right hemicolectomy (total duration of inclusion 3 months) N= 40 centers N = 310 videos

1. METC approval for the use of anonymized videos of a laparoscopic procedure and collection of corresponding clinical outcomes.
2. Approaching hospitals for participation (high volume centers (50+ colon cancers).
3. Prospective inclusion of consecutive patients undergoing laparoscopic right hemicolectomy in the participating hospitals in three months.
2. Development of Standard Laparoscopic Right Hemicolectomy: an (inter)national Delphi study

1. Approaching specialists to participate in the Delphi method (from participating hospitals in step 1).
2. Identification of crucial steps and measures according to literature and expert's opinion (Delphi method).
3. Documentation of steps and the order in which they need to be performed, development of a competency assessment tool (CAT).
3. Skills center training facility

a. Training the participating surgeons in the method of the standardized laparoscopic right hemicolectomy, as consented in the Delphi method.
4. Implementation of the standardized laparoscopic right hemicolectomy with proctoring during another period with prospective inclusion of consecutive patients with collection of surgical videos in all participating hospitals (N=40 centers, total 310 videos)

1. Rating videos.
2. Comparing with pre-implementation performance based on outcome measures reflecting oncological quality of surgery, and 30-day clinical outcomes.
3. Comparing with pre-implementation performance based on the long-term outcomes. (3-year DFS and 5-year OS).
5. Implementing standardised lap right hemicolectomy (after learning curve without proctoring)

1. Consecutive inclusion of patients (n=310)
2. CT imaging
3. Video analysis
4. Competency analysis
5. Variation analysis
6. Clinico pathological data

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonic Carcinoma Laparoscopic Right Hemicolectomy Standardisation Training Delphi Study Implementation Consolidation Assessment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

A prospective interventional sequential cohort study with a transition period
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical variations laparoscopic right hemicolectomy

Group Type NO_INTERVENTION

No interventions assigned to this group

Implementing standardised laparoscopic right hemicolectomy with proctoring

Group Type ACTIVE_COMPARATOR

Implementation standardised laparoscopic right hemicolectomy with proctoring

Intervention Type PROCEDURE

Implementation standardised laparoscopic right hemicolectomy with proctoring

Implementing standardised laparoscopic right hemicolectomy without proctoring

Group Type ACTIVE_COMPARATOR

Implementation standardised laparoscopic right hemicolectomy without proctoring

Intervention Type PROCEDURE

Implementation standardised laparoscopic right hemicolectomy without proctoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implementation standardised laparoscopic right hemicolectomy with proctoring

Implementation standardised laparoscopic right hemicolectomy with proctoring

Intervention Type PROCEDURE

Implementation standardised laparoscopic right hemicolectomy without proctoring

Implementation standardised laparoscopic right hemicolectomy without proctoring

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum, ascending colon or hepatic flexure;
* Age above 18 years;
* cTNM stage 1-3 (CT-staged);
* No prior midline or transverse laparotomy;
* ASA1-3;
* No immune modulating medication.

Exclusion Criteria

* cT4b;
* Perforated disease;
* Acute obstruction;
* Emergency operation;
* Appendiceal cancer;
* Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prof. dr. P.J. Tanis, colorectal surgeon

UNKNOWN

Sponsor Role collaborator

Dr. B.R. Toorenvliet, colorectal surgeon

UNKNOWN

Sponsor Role collaborator

D. Miskovic, St Marks hospital London, UK

UNKNOWN

Sponsor Role collaborator

S. Benz, Klinikverbund SuedWest, Böblingen, Germany

UNKNOWN

Sponsor Role collaborator

F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria

UNKNOWN

Sponsor Role collaborator

C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark

UNKNOWN

Sponsor Role collaborator

Drs. A.A.J. Grüter

UNKNOWN

Sponsor Role collaborator

Dr. U.K. Coblijn

UNKNOWN

Sponsor Role collaborator

Dr. H.L. van Westreenen

UNKNOWN

Sponsor Role collaborator

Dr. C. Sietses

UNKNOWN

Sponsor Role collaborator

Prof. dr. E.C.J. Consten

UNKNOWN

Sponsor Role collaborator

Dr. A.W.H. van de Ven

UNKNOWN

Sponsor Role collaborator

Dr. P. van Duijvendijk

UNKNOWN

Sponsor Role collaborator

Dr. S. van Aalten

UNKNOWN

Sponsor Role collaborator

Dr. F. den Boer

UNKNOWN

Sponsor Role collaborator

Dr. J.W.A. Leijtens

UNKNOWN

Sponsor Role collaborator

Dr. C. Hoff

UNKNOWN

Sponsor Role collaborator

Dr. O. van Ruler

UNKNOWN

Sponsor Role collaborator

Dr. G. D. Slooter

UNKNOWN

Sponsor Role collaborator

Prof. dr. J. Lange

UNKNOWN

Sponsor Role collaborator

Prof. dr. G.J. Kleinrensink

UNKNOWN

Sponsor Role collaborator

Amsterdam UMC, location VUmc

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jurriaan B. Tuynman

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amsterdam UMC, location VUmc

Amsterdam, North Holland, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexander A.J. Grüter, MD

Role: primary

+316 45552015

Usha K. Coblijn, MD, PhD

Role: backup

+316 43469794

References

Explore related publications, articles, or registry entries linked to this study.

Gruter AAJ, Coblijn UK, Toorenvliet BR, Tanis PJ, Tuynman JB; Right Collaborators Group. National implementation of an optimal standardised technique for right-sided colon cancer: protocol of an interventional sequential cohort study (Right study). Tech Coloproctol. 2023 Nov;27(11):1083-1090. doi: 10.1007/s10151-023-02801-6. Epub 2023 Apr 25.

Reference Type DERIVED
PMID: 37097330 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021.0273

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EAST-west Colorectal Study
NCT05544487 UNKNOWN
PreColo Practice Variation
NCT03682133 TERMINATED